Status: Not yet recruiting
A Clinical Trial to Evaluate the Safety and Efficacy of an Implantable Wireless Brain-Computer Interface（BCI）System NEO in Patients With Tetraplegia
To evaluate the safety and efficacy of a Minimally Invasive Wireless Implantable Brain-Computer Interface (BCI) System NEO in patients with tetraplegia and to provide a basis for product registration. Through brain-computer interface alternative technology, patients can control the external equipment with brain signals to improve the patient's quality of life.
Participants needed: 32
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Neuracle Medical Technology(Shanghai) Co.,Ltd.Updated: May 25, 2025Locations: 2
Eligibility criteria
Age between 18 and 65 years old, no restriction on gender. [+7]
Without the consent of the patient or the patient's legal guardian. [+12]